Bloomington, Indiana — According to state and local development sources, Simtra BioPharma Solutions plans to invest $250,000,000.00 to build out 150,000 square feet of new space in Bloomington. The company is creating 130 new jobs at this facility. The company plans to occupy the new space at 927 S Curry Pike building b in Bloomington, on or about December 1, 2026. According to the company website As a premier, independently owned CDMO with over 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with us when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer our clients tailored and versatile solutions to help them bring their products to market so they can get to the patients who need them. (Simtra is a tradename of Baxter Oncology GmbH and Baxter Pharmaceutical LLC)

To learn more about Simtra BioPharma Solutions, visit http://biopharmasolutions.baxter.com/

Company Contact:
Franco Negron, Chief Executive Officer
812-333-0887

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.